WIKIMEDIA, ANDREW BOSSI
On Tuesday (May 22), the US House of Representatives passed controversial legislation that will allow patients with life-threatening illnesses to use experimental medications without the approval of the Food and Drug Administration. The Senate already passed the bill in August 2017. After some wrangling with the language, the House passed the Senate’s version at the prodding of the White House, most recently expressed in a statement released Monday (May 21). President Donald Trump is expected to sign the bill quickly, according to The Washington Post.
“Far too many patients in our country are faced with terminal illnesses for which there are no treatments approved by the Food and Drug Administration (FDA),” the White House statement reads. “The Administration believes that these patients and their families ...
